Viewing Study NCT04193293


Ignite Creation Date: 2025-12-25 @ 1:08 AM
Ignite Modification Date: 2026-01-01 @ 3:39 AM
Study NCT ID: NCT04193293
Status: TERMINATED
Last Update Posted: 2023-09-21
First Post: 2019-12-04
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study of Duvelisib in Combination With Pembrolizumab in Head and Neck Cancer
Sponsor: SecuraBio
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2020-06-01
Start Date Type: ACTUAL
Primary Completion Date: 2020-12-10
Primary Completion Date Type: ACTUAL
Completion Date: 2020-12-10
Completion Date Type: ACTUAL
First Submit Date: 2019-12-04
First Submit QC Date: None
Study First Post Date: 2019-12-10
Study First Post Date Type: ACTUAL
Results First Submit Date: 2023-03-14
Results First Submit QC Date: None
Results First Post Date: 2023-04-07
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2023-09-07
Last Update Post Date: 2023-09-21
Last Update Post Date Type: ACTUAL